SCHEMBL14901148

SCHEMBL14901148

COc1cc(C)cc(Nc2ccc3ncc(-c4ccn(C)c4)nc3n2)c1

nearest known ligand 0.46

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
FGFR3 P22607 9/20 0.46
KDR P35968 4/20 0.46
PIK3CA P42336 8/20 0.44
MAPK1 P28482 7/20 0.44
MAPK8 P45983 7/20 0.44
MAPK9 P45984 7/20 0.44
MAPK10 P53779 7/20 0.44
FGFR1 P11362 7/20 0.41
FGFR2 P21802 7/20 0.41
FGFR4 P22455 6/20 0.41
IGF1R P08069 1/20 0.37
FLT3 P36888 2/20 0.35
PDGFRB P09619 2/20 0.34
PDGFRA P16234 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16126910 0.94 FGFR3 (0.51) FGFR3KDRPIK3CAMAPK1MAPK8
SCHEMBL14901118 0.78 MAPK1 (0.53) FGFR3KDRPIK3CAMAPK1MAPK8
SCHEMBL14901221 0.77 MAPK1 (0.53) FGFR3KDRPIK3CAMAPK1MAPK8
SCHEMBL14901143 0.75 MAPK1 (0.51) FGFR3KDRPIK3CAMAPK1MAPK8
SCHEMBL14901213 0.74 PIK3CA (0.53) FGFR3KDRPIK3CAMAPK1MAPK8
SCHEMBL16133814 0.70 FGFR3 (0.54) FGFR3KDRFGFR1FGFR2FGFR4
SCHEMBL5759671 0.70 PDGFRB (0.55) PIK3CAMAPK1MAPK8MAPK9MAPK10
SCHEMBL14901222 0.69 FGFR3 (0.55) FGFR3KDRPIK3CAMAPK1MAPK8
SCHEMBL14901126 0.69 FGFR3 (0.40) FGFR3KDRPIK3CAMAPK1MAPK8
SCHEMBL17035955 0.69 FGFR3 (0.77) FGFR3KDRFGFR1FGFR2FGFR4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013061080-A1 ANTICANCER PYRIDOPYRAZINES VIA THE INHIBITION OF FGFR KINASES ASTEX THERAPEUTICS LIMITED (GB) 2013-05-02 WO disclosed